Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 16.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 26.00
  • 52 Week Low: 10.75
  • Currency: UK Pounds
  • Shares Issued: 91.43m
  • Volume: 0
  • Market Cap: 15.31m
  • RiskGrade: 235

Synairgen Overview

Synairgen is in the pharma and biotech sector and is currently trading at 16.75p per share. In the last year Synairgen's share price has ranged from 10.75p to 26.00p.

1 Day Chart (22-10-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 32.0% n/a
ROCE 24.8%  
Latest F'cast
P/E 8.7 n/a
PEG n/a n/a
Pr/Revenue 3.0 n/a
Pr/Book 2.3  
Latest F'cast
Revenue n/a -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Synairgen Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 n/a (2.27) (2.72)p n/a n/a n/a n/a 0.0%
31-Dec-14 4.29 1.12 1.42p 22.9 n/a n/a n/a 0.0%
31-Dec-15 0.03 (2.56) (2.47)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (3.40) (3.08)p n/a n/a n/a n/a 0.0%
31-Dec-17 5.03 1.63 1.93p 5.6 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Synairgen Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 n/a (5.50) (4.70)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (3.90) (2.90)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Synairgen Company Announcements

Holding(s) in Company 22-Oct-2018 10:05 RNS
Part 2 start of Phase II COPD trial 22-Oct-2018 07:00 RNS
Holding(s) in Company 16-Oct-2018 15:01 RNS

Latest Synairgen Director Deals

Traded Action Notifier PriceAmountValue
12-Oct-18 Buy John C Ward 16.00p 62,500 10,000.00
12-Oct-18 Buy Phillip David Monk 16.00p 46,875 7,500.00
12-Oct-18 Buy Richard J Marsden 16.00p 156,250 25,000.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Synairgen Market Data

Currency UK Pounds
Share Price 16.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 26.00
52 Week Low 10.75
Volume 0
Shares Issued 91.43m
Market Cap 15.31m
RiskGrade 235

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.70% above the market average35.70% above the market average35.70% above the market average35.70% above the market average35.70% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
Price Trend
62.54% above the market average62.54% above the market average62.54% above the market average62.54% above the market average62.54% above the market average
73.77% above the sector average73.77% above the sector average73.77% above the sector average73.77% above the sector average73.77% above the sector average
Income Not Available
Growth Not Available

Synairgen Dividends

No dividends found

Trades for --2018

Time Volume / Share Price
0 @ 0.000p

Synairgen Key Personnel

CEO Richard J Marsden
Finance Director John C Ward

Top of Page